HAE Crosses Above Average Analyst Target
In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $110.45, changing hands for $119.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.